PTEN gene mutations are associated with somatic and hereditary cancers, as well as with neurodevelopmental alterations, and heterozygous germline PTEN mutations define the PTEN hamartoma tumor syndrome (PHTS) disorder, a rare disease with a prevalence of about 1/200,000 [13,14]. This evidence concerns the gene PTEN and hereditary cancer.